Selected research
Industry Research
Hydrophilic Coronary Stents Industry Research Report 2026
Market perspective
The global Hydrophilic Coronary Stents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hydrophilic Coronary Stents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hydrophilic Coronary Stents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hydrophilic Coronary Stents include Lepu Medical, USM Healthcare Medical Devices Factory, Rontis Medical, Meril Life Sciences, Genoss, Degania Silicone and Cardionovum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hydrophilic Coronary Stents market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hydrophilic Coronary Stents Market by Company
Lepu Medical
USM Healthcare Medical Devices Factory
Rontis Medical
Meril Life Sciences
Genoss
Degania Silicone
Cardionovum
Hydrophilic Coronary Stents Segment by Type
Metal Stents
Polymer Stents
Hydrophilic Coronary Stents Segment by Application
Drug-Eluting
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Hydrophilic Coronary Stents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrophilic Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydrophilic Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrophilic Coronary Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hydrophilic Coronary Stents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hydrophilic Coronary Stents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hydrophilic Coronary Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metal Stents
- Polymer Stents
Applications
- Drug-Eluting
- Post-Procedure Management
- Percutaneous Coronary Intervention (PCI)
Companies covered
- Lepu Medical
- USM Healthcare Medical Devices Factory
- Rontis Medical
- Meril Life Sciences
- Genoss
- Degania Silicone
- Cardionovum
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hydrophilic Coronary Stents Market Size (2021-2032)
- 2.2.2 Global Hydrophilic Coronary Stents Sales (2021-2032)
- 2.2.3 Global Hydrophilic Coronary Stents Market Average Price (2021-2032)
- 2.3 Hydrophilic Coronary Stents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Metal Stents
- 2.3.3 Polymer Stents
- 2.4 Hydrophilic Coronary Stents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug-Eluting
- 2.4.3 Post-Procedure Management
- 2.4.4 Percutaneous Coronary Intervention (PCI)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hydrophilic Coronary Stents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hydrophilic Coronary Stents Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Hydrophilic Coronary Stents Revenue of Manufacturers (2021-2026)
- 3.4 Global Hydrophilic Coronary Stents Average Price by Manufacturers (2021-2026)
- 3.5 Global Hydrophilic Coronary Stents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hydrophilic Coronary Stents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hydrophilic Coronary Stents, Product Type & Application
- 3.8 Global Manufacturers of Hydrophilic Coronary Stents, Established Date
- 3.9 Global Hydrophilic Coronary Stents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lepu Medical
- 4.1.1 Lepu Medical Company Information
- 4.1.2 Lepu Medical Business Overview
- 4.1.3 Lepu Medical Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lepu Medical Hydrophilic Coronary Stents Product Portfolio
- 4.1.5 Lepu Medical Recent Developments
- 4.2 USM Healthcare Medical Devices Factory
- 4.2.1 USM Healthcare Medical Devices Factory Company Information
- 4.2.2 USM Healthcare Medical Devices Factory Business Overview
- 4.2.3 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Product Portfolio
- 4.2.5 USM Healthcare Medical Devices Factory Recent Developments
- 4.3 Rontis Medical
- 4.3.1 Rontis Medical Company Information
- 4.3.2 Rontis Medical Business Overview
- 4.3.3 Rontis Medical Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Rontis Medical Hydrophilic Coronary Stents Product Portfolio
- 4.3.5 Rontis Medical Recent Developments
- 4.4 Meril Life Sciences
- 4.4.1 Meril Life Sciences Company Information
- 4.4.2 Meril Life Sciences Business Overview
- 4.4.3 Meril Life Sciences Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Meril Life Sciences Hydrophilic Coronary Stents Product Portfolio
- 4.4.5 Meril Life Sciences Recent Developments
- 4.5 Genoss
- 4.5.1 Genoss Company Information
- 4.5.2 Genoss Business Overview
- 4.5.3 Genoss Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Genoss Hydrophilic Coronary Stents Product Portfolio
- 4.5.5 Genoss Recent Developments
- 4.6 Degania Silicone
- 4.6.1 Degania Silicone Company Information
- 4.6.2 Degania Silicone Business Overview
- 4.6.3 Degania Silicone Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Degania Silicone Hydrophilic Coronary Stents Product Portfolio
- 4.6.5 Degania Silicone Recent Developments
- 4.7 Cardionovum
- 4.7.1 Cardionovum Company Information
- 4.7.2 Cardionovum Business Overview
- 4.7.3 Cardionovum Hydrophilic Coronary Stents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cardionovum Hydrophilic Coronary Stents Product Portfolio
- 4.7.5 Cardionovum Recent Developments
5 Global Hydrophilic Coronary Stents Market Scenario by Region
- 5.1 Global Hydrophilic Coronary Stents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hydrophilic Coronary Stents Sales by Region: 2021-2032
- 5.2.1 Global Hydrophilic Coronary Stents Sales by Region: 2021-2026
- 5.2.2 Global Hydrophilic Coronary Stents Sales by Region: 2027-2032
- 5.3 Global Hydrophilic Coronary Stents Revenue by Region: 2021-2032
- 5.3.1 Global Hydrophilic Coronary Stents Revenue by Region: 2021-2026
- 5.3.2 Global Hydrophilic Coronary Stents Revenue by Region: 2027-2032
- 5.4 North America Hydrophilic Coronary Stents Market Facts & Figures by Country
- 5.4.1 North America Hydrophilic Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 5.4.3 North America Hydrophilic Coronary Stents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hydrophilic Coronary Stents Market Facts & Figures by Country
- 5.5.1 Europe Hydrophilic Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 5.5.3 Europe Hydrophilic Coronary Stents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hydrophilic Coronary Stents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hydrophilic Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hydrophilic Coronary Stents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hydrophilic Coronary Stents Market Facts & Figures by Country
- 5.7.1 South America Hydrophilic Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 5.7.3 South America Hydrophilic Coronary Stents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hydrophilic Coronary Stents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hydrophilic Coronary Stents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hydrophilic Coronary Stents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hydrophilic Coronary Stents Sales by Type (2021-2032)
- 6.1.1 Global Hydrophilic Coronary Stents Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Hydrophilic Coronary Stents Sales Market Share by Type (2021-2032)
- 6.2 Global Hydrophilic Coronary Stents Revenue by Type (2021-2032)
- 6.2.1 Global Hydrophilic Coronary Stents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hydrophilic Coronary Stents Revenue Market Share by Type (2021-2032)
- 6.3 Global Hydrophilic Coronary Stents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hydrophilic Coronary Stents Sales by Application (2021-2032)
- 7.1.1 Global Hydrophilic Coronary Stents Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Hydrophilic Coronary Stents Sales Market Share by Application (2021-2032)
- 7.2 Global Hydrophilic Coronary Stents Revenue by Application (2021-2032)
- 7.2.1 Global Hydrophilic Coronary Stents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hydrophilic Coronary Stents Revenue Market Share by Application (2021-2032)
- 7.3 Global Hydrophilic Coronary Stents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hydrophilic Coronary Stents Value Chain Analysis
- 8.1.1 Hydrophilic Coronary Stents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hydrophilic Coronary Stents Production Mode & Process
- 8.2 Hydrophilic Coronary Stents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hydrophilic Coronary Stents Distributors
- 8.2.3 Hydrophilic Coronary Stents Customers
9 Global Hydrophilic Coronary Stents Analyzing Market Dynamics
- 9.1 Hydrophilic Coronary Stents Industry Trends
- 9.2 Hydrophilic Coronary Stents Industry Drivers
- 9.3 Hydrophilic Coronary Stents Industry Opportunities and Challenges
- 9.4 Hydrophilic Coronary Stents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst